US 10206995
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
granted A61KA61K2039/5252A61K2039/5254
Quick answer
US patent 10206995 (Live attenuated virus vaccines for la crosse virus and other bunyaviridae) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/5252, A61K2039/5254, A61K39/00, A61K39/12